70325-82-5 Usage
Uses
Used in Organic Synthesis:
2-Methyl-1-(phenylmethyl)-3-pyrrolidinamine is used as a synthetic building block for the development of various organic compounds. Its unique structure, which includes a methyl group and a phenylmethyl group attached to a pyrrolidine ring, allows it to participate in a range of chemical reactions, facilitating the synthesis of diverse molecules with potential applications in pharmaceuticals, materials science, and other areas.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Methyl-1-(phenylmethyl)-3-pyrrolidinamine is utilized as an intermediate in the synthesis of various drugs and drug candidates. Its ability to form a variety of chemical bonds and its compatibility with different functional groups make it a versatile component in the development of new medications, particularly those targeting complex biological pathways.
Used in Materials Science:
2-Methyl-1-(phenylmethyl)-3-pyrrolidinamine also finds application in the field of materials science, where it can be used to create novel materials with specific properties. Its incorporation into polymers, for instance, can lead to the development of materials with enhanced mechanical, thermal, or electrical characteristics, depending on the desired application.
Check Digit Verification of cas no
The CAS Registry Mumber 70325-82-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,3,2 and 5 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 70325-82:
(7*7)+(6*0)+(5*3)+(4*2)+(3*5)+(2*8)+(1*2)=105
105 % 10 = 5
So 70325-82-5 is a valid CAS Registry Number.
70325-82-5Relevant academic research and scientific papers
A new entry into cis-3-amino-2-methylpyrrolidines via ring expansion of 2-(2-hydroxyethyl)-3-methylaziridines
D'Hooghe, Matthias,Aelterman, Wim,De Kimpe, Norbert
experimental part, p. 135 - 141 (2009/04/07)
3-Amino-2-methylpyrrolidines were prepared via a novel protocol, involving the reductive ring closure and O-deprotection of γ-acetoxy-α- chloroketimines towards 2-(2-hydroxyethyl)-3-methylaziridines, followed by ring expansion of the latter into 3-bromopy
